US Patent

US7863288 — Compounds and methods for kinase modulation, and indications therefor

Composition of Matter · Assigned to Plexxikon Inc · Expires 2029-06-20 · 3y remaining

Vulnerability score 15/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects compounds that modulate protein kinases and methods for using these compounds to treat diseases associated with aberrant protein kinase activity.

USPTO Abstract

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Drugs covered by this patent

Patent Metadata

Patent number
US7863288
Jurisdiction
US
Classification
Composition of Matter
Expires
2029-06-20
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.